MedTrace Logo

Understanding Neonatal Jaundice in Rwanda

NCT03184948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2020-04-01

No results posted yet for this study

Summary

This study exploits the distribution of low-cost high-quality phototherapy devices (Brilliance by D-Rev) to public hospitals in Rwanda to assess whether the provision of improved technology improves health care for infant jaundice. Specifically, the investigators are interested in measuring whether the provision of an additional high-quality phototherapy device, a known effective treatment for jaundice, successfully translates into improved care of neonatal jaundice in Rwanda where the burden of jaundice is particularly high.

Conditions

  • Jaundice, Neonatal

Interventions

DEVICE

Brilliance

The intervention is the provision of the Brilliance phototherapy machines to hospitals. This device is to be provided to facilities regardless of the study -- the study's involvement has been to collaborate with the Ministry of Health so that Brilliance is distributed in a randomized staggered method. In that sense, the study may be considered observational, as the study is not driving whether or not a hospital receives Brilliance, only when it receives Brilliance in a short time frame.

Sponsors & Collaborators

  • Rwanda Pediatric Association

    collaborator UNKNOWN

  • Ministry of Health, Rwanda

    collaborator OTHER_GOV

  • Rwanda Bio-Medical Center

    collaborator UNKNOWN

  • Child Relief International

    collaborator UNKNOWN

  • D-Rev

    collaborator UNKNOWN

  • University of California, Merced

    lead OTHER

Principal Investigators

  • Ketki Sheth, PhD · University of California, Merced

  • Lisine Tuysenge, MD · Rwanda Pediatric Association

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-29
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • Rwanda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03184948 on ClinicalTrials.gov